Overview

Efficacy And Tolerability Of Alpha Lipoic Acid And Vitamin B Preparation In Carpal Tunnel Syndrome

Status:
COMPLETED
Trial end date:
2024-09-30
Target enrollment:
Participant gender:
Summary
The goal of this clinical trial is to assess the effectiveness and safety of an oral combination of alpha lipoic acid (ALA) and vitamin B complex in treating mild to moderate carpal tunnel syndrome (CTS) in adults. The main questions it aims to answer are: * Does the combination of ALA and vitamin B improve nerve function (based on electrodiagnostic studies) in patients with CTS? * Does this treatment reduce CTS-related symptoms and improve quality of life? * What side effects, if any, do participants experience while taking the treatment? Researchers will compare the combination of ALA and vitamin B to a placebo (a look-alike substance that contains no active drug) to evaluate its effectiveness. Participants will: * Take the ALA and vitamin B combination or a placebo once daily for 6 months. * Attend clinic visits at the start of the study, after 3 months, and after 6 months for physical examinations, nerve conduction studies, and to complete questionnaires about their symptoms and quality of life. * Receive follow-up phone calls and reminder messages to ensure medication compliance and attendance at scheduled visits.
Phase:
PHASE2
Details
Lead Sponsor:
Universiti Putra Malaysia
Collaborator:
BREGO Life Sciences Sdn Bhd